
Predicting relapse in rheumatoid arthritis during DMARD tapering: A systematic review of musculoskeletal ultrasound clinical efficacy and economic evaluations compared to DAS28-based clinimetrics
<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxOWEIweW04Y2p1QWJDVVVPcnJhTjJzQlRFSXd0WVRjMV9QYkdNZVktNEhtdExDLThxS3M2eXlpOWRaN0hLN0Jwa19iQmxtZW5kbzNYQmtMNEs1RjVqSFg4cEhyLXd2aS1mYzdpNG9yNmRJTnJuNDI3bm5faWFHVHhYelpkSXVydmdXU1V0MEJzeWdaUVd3NEtDaXRmS0F0V2l4M29YQ1g1R2hMbUNsb0d2RTh3RVpYUC1sQzZIUG9XY2VfNERmRkpTOUFnQlZ2ampkd0N4TFBqRQ?oc=5" target="_blank">Predicting relapse in rheumatoid arthritis during DMARD tapering: A systematic review of musculoskeletal ultrasound clinical efficacy and economic evaluations compared to DAS28-based clinimetrics</a>&nbsp;&nbsp;<font color="#6f6f6f">www.elsevier.com</font>
